Skip to main content
. 2018;64(2):64–72. doi: 10.5387/fms.2018-10

Fig. 4.

Fig. 4.

RFS using the Kaplan-Meier method statistically assessed by the log-rank test. (A): Patients with NLR ≥ 2.9 showed a statistically lower RFS than those with NLR < 2.9 (p = 0.007). (B): Patients with LMR ≤ 2.4 exhibited a statistically lower RFS than those with LMR > 2.4 (p = 0.008). (C): When analyzed in stage II + III disease patients, those with NLR ≥ 2.9, or MDSCs ≥ 3.2% showed a statistically lower RFS than those with NLR < 2.9 (p = 0.044). (D): When analyzed in stage II + III disease patients, those with LMR ≤ 2.4 showed a statistically lower RFS than those with LMR > 2.4 (p = 0.015). (E): When analyzed in stage II + III disease patients, those with MDSCs ≥ 3.2% showed a statistically lower RFS than those with MDSCs < 3.2% (p = 0.038). MDSCs could not be examined in three out of 26 patients with stage II + III disease.